TT-235

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTT-235
Drug Alias NameTT-235
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionOxytocin receptor antagonists
TargetsOxytocin receptor
Therapy Area/IndicationsObstetric Labor, Premature
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNorthwest University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNorthwest UniversityMitsubishi Tanabe Pharma
Active IndicationsN/A
Inactive IndicationsObstetric Labor, Premature

Other Information

ATC CodeN/A
Related LinksN/A